| abstract |
The present disclosure discloses a therapeutically effective amount of a therapeutically effective amount of a selective α-adrenaline receptor agonist or anticholinergic agent or a pharmaceutically acceptable salt or stereoisomer thereof of a therapeutically effective amount of lipoic acid or a pharmaceutically acceptable amount thereof. A pharmaceutical composition comprising in combination with a salt or steric isomer, wherein the selective α-adrenaline receptor agonist or anticholinergic agent is pilocarpine, brimonidin and oxymethazoline or a pharmaceutically acceptable salt or steric thereof. With respect to pharmaceutical compositions selected from the group consisting of isomers, and the use of such pharmaceutical compositions in the treatment or alleviation of dry mouth, skin disorders and eye disorders. [Selection diagram] None |